1. Home
  2. VTEX vs PRME Comparison

VTEX vs PRME Comparison

Compare VTEX & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VTEX

VTEX

VTEX

HOLD

Current Price

$3.92

Market Cap

752.7M

Sector

Technology

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.54

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTEX
PRME
Founded
1999
2019
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
752.7M
666.1M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
VTEX
PRME
Price
$3.92
$3.54
Analyst Decision
Buy
Buy
Analyst Count
6
6
Target Price
$5.97
$7.56
AVG Volume (30 Days)
1.0M
1.7M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.18
EPS
N/A
N/A
Revenue
N/A
$4,632,000.00
Revenue This Year
$12.78
$7.06
Revenue Next Year
$9.63
$47.01
P/E Ratio
$43.33
N/A
Revenue Growth
N/A
55.28
52 Week Low
$2.84
$1.11
52 Week High
$6.82
$6.94

Technical Indicators

Market Signals
Indicator
VTEX
PRME
Relative Strength Index (RSI) 46.90 45.49
Support Level $3.92 $3.17
Resistance Level $4.21 $3.94
Average True Range (ATR) 0.18 0.22
MACD -0.04 -0.00
Stochastic Oscillator 16.15 36.84

Price Performance

Historical Comparison
VTEX
PRME

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: